La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Nanosonics Résultats passés
Passé contrôle des critères 5/6
Nanosonics has been growing earnings at an average annual rate of 5.6%, while the Medical Equipment industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 15.9% per year. Nanosonics's return on equity is 8.9%, and it has net margins of 9.6%.
Informations clés
5.6%
Taux de croissance des bénéfices
5.5%
Taux de croissance du BPA
Medical Equipment Croissance de l'industrie | 5.8% |
Taux de croissance des recettes | 15.9% |
Rendement des fonds propres | 8.9% |
Marge nette | 9.6% |
Prochaine mise à jour des résultats | 27 Aug 2024 |
Mises à jour récentes des performances passées
Recent updates
Returns On Capital At Nanosonics (ASX:NAN) Paint A Concerning Picture
Feb 27Some Confidence Is Lacking In Nanosonics Limited (ASX:NAN) As Shares Slide 33%
Jan 24Is Nanosonics Limited (ASX:NAN) Potentially Undervalued?
Nov 08Investors Will Want Nanosonics' (ASX:NAN) Growth In ROCE To Persist
Oct 04Is Nanosonics Limited (ASX:NAN) Potentially Undervalued?
Jul 12Nanosonics (ASX:NAN) Will Be Hoping To Turn Its Returns On Capital Around
May 16Is Now The Time To Look At Buying Nanosonics Limited (ASX:NAN)?
Feb 09This Is Why Nanosonics Limited's (ASX:NAN) CEO Compensation Looks Appropriate
Nov 11A Look At The Fair Value Of Nanosonics Limited (ASX:NAN)
Oct 28What Does Nanosonics Limited's (ASX:NAN) Share Price Indicate?
Oct 06A Look At The Fair Value Of Nanosonics Limited (ASX:NAN)
Jul 18At AU$3.36, Is Nanosonics Limited (ASX:NAN) Worth Looking At Closely?
Jun 26Nanosonics (ASX:NAN) Will Want To Turn Around Its Return Trends
Jun 07A Look At The Intrinsic Value Of Nanosonics Limited (ASX:NAN)
Mar 08Nanosonics Limited (ASX:NAN) Analysts Just Cut Their EPS Forecasts
Feb 15Is Now The Time To Look At Buying Nanosonics Limited (ASX:NAN)?
Feb 02Nanosonics Limited's (ASX:NAN) CEO Looks Due For A Compensation Raise
Nov 12Returns Are Gaining Momentum At Nanosonics (ASX:NAN)
Aug 03An Intrinsic Calculation For Nanosonics Limited (ASX:NAN) Suggests It's 21% Undervalued
Mar 30Returns On Capital - An Important Metric For Nanosonics (ASX:NAN)
Mar 15Time To Worry? Analysts Are Downgrading Their Nanosonics Limited (ASX:NAN) Outlook
Feb 28Nanosonics Limited's (ASX:NAN) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Feb 19Is There Now An Opportunity In Nanosonics Limited (ASX:NAN)?
Feb 07What Did Nanosonics' (ASX:NAN) CEO Take Home Last Year?
Jan 26How Much Of Nanosonics Limited (ASX:NAN) Do Insiders Own?
Jan 14Here's Why Nanosonics's (ASX:NAN) Statutory Earnings Are Arguably Too Conservative
Jan 01Estimating The Intrinsic Value Of Nanosonics Limited (ASX:NAN)
Dec 20Is There More Growth In Store For Nanosonics' (ASX:NAN) Returns On Capital?
Dec 07Can You Imagine How Elated Nanosonics' (ASX:NAN) Shareholders Feel About Its 302% Share Price Gain?
Nov 25Ventilation des recettes et des dépenses
Comment Nanosonics gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
---|---|---|---|---|
31 Dec 23 | 164 | 16 | 88 | 32 |
30 Sep 23 | 165 | 18 | 87 | 31 |
30 Jun 23 | 166 | 20 | 85 | 29 |
31 Mar 23 | 154 | 15 | 81 | 27 |
31 Dec 22 | 141 | 10 | 77 | 25 |
30 Sep 22 | 131 | 7 | 73 | 24 |
30 Jun 22 | 120 | 4 | 68 | 22 |
31 Mar 22 | 120 | 7 | 64 | 21 |
31 Dec 21 | 121 | 11 | 60 | 20 |
30 Sep 21 | 112 | 10 | 57 | 19 |
30 Jun 21 | 103 | 9 | 54 | 17 |
31 Mar 21 | 99 | 7 | 51 | 17 |
31 Dec 20 | 95 | 6 | 49 | 16 |
30 Sep 20 | 97 | 8 | 48 | 16 |
30 Jun 20 | 100 | 10 | 48 | 16 |
31 Mar 20 | 96 | 11 | 47 | 14 |
31 Dec 19 | 92 | 12 | 46 | 13 |
30 Sep 19 | 88 | 13 | 42 | 12 |
30 Jun 19 | 84 | 14 | 38 | 11 |
31 Mar 19 | 78 | 12 | 36 | 11 |
31 Dec 18 | 71 | 11 | 34 | 11 |
30 Sep 18 | 66 | 8 | 33 | 10 |
30 Jun 18 | 61 | 6 | 33 | 10 |
31 Mar 18 | 61 | 6 | 31 | 10 |
31 Dec 17 | 61 | 6 | 29 | 10 |
30 Sep 17 | 64 | 16 | 28 | 10 |
30 Jun 17 | 68 | 26 | 28 | 9 |
31 Mar 17 | 65 | 26 | 26 | 9 |
31 Dec 16 | 63 | 25 | 25 | 8 |
30 Sep 16 | 53 | 13 | 25 | 8 |
30 Jun 16 | 43 | 0 | 25 | 7 |
31 Mar 16 | 33 | -5 | 25 | 7 |
31 Dec 15 | 23 | -10 | 24 | 6 |
30 Sep 15 | 23 | -8 | 21 | 5 |
30 Jun 15 | 22 | -5 | 18 | 5 |
31 Mar 15 | 24 | -2 | 17 | 4 |
31 Dec 14 | 26 | 2 | 16 | 3 |
30 Sep 14 | 24 | 0 | 16 | 2 |
30 Jun 14 | 21 | -3 | 17 | 1 |
31 Mar 14 | 21 | -3 | 15 | 1 |
31 Dec 13 | 20 | -3 | 14 | 1 |
30 Sep 13 | 18 | -4 | 14 | 1 |
Des revenus de qualité: NAN a des bénéfices de haute qualité.
Augmentation de la marge bénéficiaire: NAN's current net profit margins (9.6%) are higher than last year (7.2%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: NAN's earnings have grown by 5.6% per year over the past 5 years.
Accélération de la croissance: NAN's earnings growth over the past year (53.2%) exceeds its 5-year average (5.6% per year).
Bénéfices par rapport au secteur d'activité: NAN earnings growth over the past year (53.2%) exceeded the Medical Equipment industry 10.1%.
Rendement des fonds propres
ROE élevé: NAN's Return on Equity (8.9%) is considered low.